Cellebrite DI Ltd(CLBT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 51.44 | EPS (ttm) | 0.23 | Insider Own | 49.96% | Shs Outstand | 249.4M | Perf Week | 4.93% |
| Market Cap | 3.00B | Forward P/E | 31.82 | EPS next Y | 35.88% | Insider Trans | -0.29% | Shs Float | 125.8M | Perf Month | 7.77% |
| Enterprise Value | 2.58B | PEG | 2.64 | EPS next Q | 0.09 | Inst Own | 46.19% | Short Float | 5.74% | Perf Quarter | -20.84% |
| Income | 0.06B | P/S | 5.83 | EPS this Y | -10.99% | Inst Trans | -2.7% | Short Ratio | 2.44 | Perf Half Y | -5.91% |
| Sales | 0.51B | P/B | 5.53 | EPS next 5Y | 12.07% | ROA | 6.54% | Short Interest | 7.22M | Perf YTD | -33.83% |
| Book/sh | 2.16 | P/C | 6.78 | EPS past 3/5Y | -19.38% 46.15% | ROE | 12.31% | 52W High | -40.29% ($19.98) | Perf Year | -35.51% |
| Cash/sh | 1.76 | P/FCF | 20.8 | Sales past 3/5Y | 20.68% 19.53% | ROIC | 10.48% | 52W Low | 24.53% ($9.58) | Perf 3Y | 84.96% |
| Dividend Est. | - | EV/EBITDA | 31.85 | EPS Y/Y TTM | 131.46% | Gross Margin | 82.96% | Volatility(W/M) | 2.78% 3.29% | Perf 5Y | 9.75% |
| Dividend TTM | - | EV/Sales | 5.02 | Sales Y/Y TTM | 17.76% | Oper. Margin | 11.36% | ATR (14) | 0.41 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.58 | EPS Q/Q | -67.77% | Profit Margin | 11.33% | RSI (14) | 55.93 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.6 | Sales Q/Q | 15.77% | SMA20 | 4.65% ($11.4) | Beta | 1.06 | Target Price | $15.36 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 2026/11/12 | SMA50 | 4.24% ($11.44) | Rel Volume | 0.44 | Prev Close | $12.23 |
| Employees | 1285 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | -67.53% -0.56% | SMA200 | -11.54% ($13.49) | Avg Volume(3M) | 2.96M | Price | $11.93 |
| IPO | 2020/11/6 | Option/Short | Yes/Yes | Trades | 6143 | Volume | 1,304,336 | Change | -2.45% |
🔍 This is an Israeli company that provides digital intelligence software. It offers mobile forensic and investigation software that supports law enforcement agencies and enterprises in collecting and analyzing digital evidence, giving it exposure to the digital investigation needs of government and public-sector customers. It is a company in the digital intelligence sector.
Over the past 1 year, on the lower side
40% below its 1-year high.
Traded less than usual. That is 44% of its average volume.
Next earnings report: November 12
CLBT makes money exceptionally well
Of every $100 in sales, $11.36 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -11.0% this year.
Tap to view numbers
The price is about the industry average
For a company earning $100 a year, you would pay $5,144. Peers typically go for $3,224.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be +9.8%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 46.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #57 of 181 in the industry
Based on market cap of $3B.
TDC#56 Teradata Corp $3B PER 7.3 CLBT#57 Cellebrite DI Ltd $3B PER 51.4 
FOUR#58 Shift4 Payments Inc $3B PER 60.7 
NTCT#59 Netscout Systems Inc $3B PER 24.7 
FIVN#60 Five9 Inc $3B PER 54.2 
FAQ
What kind of company is CLBT?
CLBT belongs to the Technology sector and operates in the Software - Infrastructure industry.
What is the market cap of CLBT?
The market cap of CLBT is approximately $3.0B, ranking 1,760 within its sector.
What is the P/E ratio of CLBT?
CLBT has a P/E ratio of approximately 51.4x, which can be used to assess its valuation relative to the Technology sector average.
What is the 52-week high and low for CLBT?
CLBT has recorded a 52-week high of $19.98 and a low of $9.58.
